迈得医疗：预计2025年全年扣非后净利润盈利约5463.95万元

Core Viewpoint - The company expects a significant increase in net profit for the year 2025, projecting a profit of approximately 54.64 million yuan after excluding non-recurring gains and losses, driven by substantial growth in overall operating revenue and effective product delivery [1] Group 1: Performance Forecast - For the year 2025, the company anticipates a net profit of about 54.64 million yuan after excluding non-recurring gains and losses [1] - The increase in revenue is attributed to the orderly implementation of production plans and a focus on technological innovation and process iteration [1] - The blood purification and medical device combination intelligent equipment businesses are performing well, particularly due to strong demand growth in the terminal market for medical consumables [1] Group 2: Q3 Financial Results - In the first three quarters of 2025, the company's main revenue reached 225 million yuan, a year-on-year increase of 2.31% [2] - The net profit attributable to the parent company was 8.84 million yuan, up 15.82% year-on-year [2] - The third quarter alone saw a main revenue of 83.64 million yuan, representing a 54.38% year-on-year increase, with a net profit of 2.79 million yuan, up 224.07% year-on-year [2] - The company reported a gross margin of 40.19% and a debt ratio of 29.86% [2]